Another limitation is that although our findings speculate that high-dose ascorbate stimulates SerpinG1 secretion via tubular mitophagy, the detailed mechanisms of how high-dose ascorbate protects clinical patients against septic AKI remain unclear. The gene discussed is SERPING1; the disease is acute kidney injury.